GB Patent

GB201512369D0 — Novel peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

Assigned to Immatics Biotechnologies GmbH · Expires 2015-08-19 · 11y expired

What this patent protects

Patent listed against Pemazyre.

Drugs covered by this patent

Patent Metadata

Patent number
GB201512369D0
Jurisdiction
GB
Classification
—
Expires
2015-08-19
Drug substance claim
No
Drug product claim
No
Assignee
Immatics Biotechnologies GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.